The federal health bureaucracy that pushed COVID mandates on every American wants you rolling up your sleeve for flu shots now — except the CDC's own vaccine advisory panel is bogged down in a court fight and hasn't even issued updated guidance this year.
What that means for ordinary Americans: the institutions directing your medical decisions are in disarray, private medical societies are stepping in to set the policy that drives state and insurance coverage, and Moderna just secured FDA approval for a new mRNA flu vaccine with billions on the line — all while the revolving door between federal health agencies and the pharmaceutical industry keeps spinning.
Both NBC 5 Chicago and WRAL reported that the CDC's independent advisory panel, which "influences state and insurance vaccine policies," is "caught in a court battle" and that the CDC "hasn't updated its advice." Neither outlet bothered to identify the parties in that lawsuit or explain what's at stake. The public is simply told the panel is sidelined; the details are left in the dark.
Stepping into the vacuum: the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, and the Infectious Diseases Society of America. These groups have posted their own vaccination guidelines. What neither outlet examined: the pharmaceutical industry's financial ties to these professional societies — the grant money, the sponsorship dollars, the advertising spend that flows from drugmakers to the organizations now filling the CDC's role.
Dr. Ryan Stanton of the American College of Emergency Physicians offered the familiar framing: vaccination "isn't a guarantee that we're going to prevent illness. But just like the seat belt in your car, it decreases risk" of the worst outcomes. The seat-belt analogy is tidy. Seat belts, though, don't generate recurring revenue for the companies that lobby the agencies recommending them.
On the flu shot itself, the medical societies say everyone 6 months and older should get one, with particular urgency for seniors, pregnant women, young children, and people with chronic conditions. The Vaccine Integrity Project at the University of Minnesota reported that flu vaccines decreased older adults' hospitalizations by 31% last year. The last two flu seasons saw "unusually high numbers of child deaths, the vast majority of them in unvaccinated kids," both outlets reported.
Then there's the new product: the FDA recently approved Moderna's mFlusiva, the first flu vaccine built on mRNA technology — the same platform that powered the COVID shots. It's approved for adults 50 and older. One study found it was 27% more effective against symptomatic illness in the 50-to-64 age group than a standard shot. Moderna's COVID vaccine revenue dwarfed projections; the company now has a fresh pipeline into the annual flu market. Neither outlet raised the question of who funded that study.
On COVID shots, a quiet shift is underway. The FDA has only formally approved updated COVID-19 vaccines for higher-risk people — those 65 and older or younger people with at least one risk factor. But the family physicians' group recommends all adults get one, with seniors advised to get a second dose six months later. The American Academy of Pediatrics recommends COVID vaccination for all children starting at 6 months. The gap between formal FDA approval and broad physician-group recommendations is where industry influence meets institutional credibility.
Both outlets presented the flu-and-COVID shot push as straightforward public health guidance. Neither asked who profits when the CDC's advisory panel goes dark and medical societies — funded by the same companies whose products they're recommending — take the wheel.
The court fight sidelining the CDC's vaccine panel deserves sunlight. So does the money trail behind every "expert says" headline. When the institutions that misled the public on COVID tell you to trust the science again, the burden of proof is on them — not on the American people asking questions.
